Wikipedia -WSS

Wikipedia

author：explore 2025-10-01 18:45:31 - browse：93838

Adam's take main illustration — Molly Ferguson/STAT

The Food and Drug Administration should halt Cassava Sciences’ ongoing clinical trials in Alzheimer’s disease. That, and other thoughts on the fallout from the City University of New York investigation that raised serious doubts about the science underpinning the company’s experimental drug simufilam.

Patient safety is paramount to the FDA, so stopping Cassava’s two Phase 3 studies is the ethically correct thing to do.The FDA has the power to place clinical holds on experimental drugs when there’s evidence of an unacceptable safety risk to study participants. Simufilam doesn’t appear to be toxic. It’s not causing dangerous side effects. But study participants can also be harmed when they volunteer for a clinical trial based on false or misleading information about a drug’s potential efficacy.

The CUNY committee charged with investigating Cassava’s principal scientific collaborator, the neuroscientist Hoau-Yan Wang, could not definitively prove that Wang faked simufilam data, but that’s only because he refused to turn over original data and primary research records that the committee had requested to examine. Wang also claimed that boxes of research records relevant to the investigation were thrown away. The investigative report was first made public last week in the journal Science.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： ALS advocates say criticism of new drugs misses bigger picture

hotspot

focus

WSS

Senator probes 340B programs at Cleveland Clinic, Bon Secours

Cigna to pay $172 million to settle Medicare Advantage fraud probe

Senator probes 340B programs at Cleveland Clinic, Bon Secours

Ethical issues complicate the benefits of medical crowdfunding

Stem cell treatment guidelines are released by FDA

Paxlovid should be available without a positive Covid test

entertainment

Wikipedia

focus

Apple is now the first public company to be valued at $3 trillion

After a drawn out lobbying fight, ARPA

Dobbs anniversary: the lost opportunity of abortion as health care

Kaiser Permanente unions announce official strike date

Psychedelics group wrestles with new pharma identity

Shingles, which affected Dianne Feinstein, is on the rise

Activists slam private health insurers over coverage restrictions

After a drawn out lobbying fight, ARPA

Bright Health sells Medicare Advantage business to Molina

FDA advisers vote against ALS treatment from BrainStorm

focus

Advances in CAR

Stem cell treatment guidelines are released by FDA

Menendez indictment could see pharma lose a key ally

Crinetics acromegaly drug succeeds in late

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Shingles, which affected Dianne Feinstein, is on the rise

hotspot

focus

hotspot

explore